Genetic factors related to endometriosis: present and future

References

• International human genome sequencing consortium. Initial sequencing and analysis of the human genome. Nature409, 860–921 (2001).
   PubMed Web of Science ®Google Scholar
• Hirschhorn JN, Daly J. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet.6, 95–108 (2005).
   PubMed Web of Science ®Google Scholar
• Sachidanandam R, Weissman D, Schmidt SC et al. International SNP map working group: a map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature409, 928–933 (2001).
   PubMed Web of Science ®Google Scholar
• Hirschhorn JN. Genetic epidemiology of Type 1 diabetes. Pediatr. Diabetes4, 87–100 (2003).
   PubMedGoogle Scholar
• Hirschhorn JN. Genetic approaches to studying common diseases and complex traits. Pediatr. Res.5, 74R–77R (2005).
   Google Scholar
• Spielman RS, Baker L, Zmijewski CM. Gene dosage and susceptibility to insulin-dependent diabetes. Ann. Hum. Genet.44, 135–150 (1980).
   PubMed Web of Science ®Google Scholar
• Giudice LC, Kao LC. Endometriosis. Lancet364, 1789–1799 (2004).
   PubMed Web of Science ®Google Scholar
• Vigano P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: epidemiology and aetiological factors. Best Pract. Res. Clin. Obstet. Gynaecol.18, 177–200 (2004).
   PubMed Web of Science ®Google Scholar
• Barlow DH, Kennedy S. Endometriosis: new genetic approaches and therapy. Annu. Rev. Med.56, 345–356 (2005).
   PubMed Web of Science ®Google Scholar
• Treloar SA, O’Connor DT, O’Connor VM, Martin NG. Genetic influences on endometriosis in an Australian twin sample. Fertil. Steril.71, 701–710 (1999).
   PubMed Web of Science ®Google Scholar
• Simpson JL, Elias S, Malinak LR, Buttram VC Jr. Heritable aspects of endometriosis. I. Genetic studies. Am. J. Obstet. Gynecol.137, 327–331 (1980).
   PubMed Web of Science ®Google Scholar
• Coxhead D, Thomas EJ. Familiar inheritance of endometriosis in a British population. A case control study. J. Obstet.Gynaecol.13, 42–44 (1993).
   Google Scholar
• Moen MH, Magnus P. The familial risk of endometriosis. Acta. Obstet. Gynecol. Scand.72, 560–564 (1993).
   PubMed Web of Science ®Google Scholar
• Stefansson H, Geirsson RT, Steinthorsdottir V et al. Genetic factors contribute to the risk of developing endometriosis. Hum. Reprod.17, 555–559 (2002).
   PubMed Web of Science ®Google Scholar
• Bischoff F, Simpson JL. Genetics of endometriosis: heritability and candidate genes. Best Pract. Res. Clin. Obstet. Gynaecol.18, 219–232 (2004).
   PubMed Web of Science ®Google Scholar
• Lander ES, Schork NJ. Genetic dissection of complex traits. Science265, 2037–2048 (1994).
   PubMed Web of Science ®Google Scholar
• Chakravarti A. Population genetics – making sense out of sequence. Nat Genet.21, 56–60 (1999).
   PubMed Web of Science ®Google Scholar
• Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet.17, 502–510 (2001).
   PubMed Web of Science ®Google Scholar
• Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature411, 599–603 (2001).
   PubMed Web of Science ®Google Scholar
• Stefansson H, Sarginson J, Kong A et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am. J. Hum. Genet.72, 83–87 (2003).
   PubMed Web of Science ®Google Scholar
• Nistico L, Buzzetti R, Pritchard LE et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, Type 1 diabetes. Belgian Diabetes Registry. Hum. Mol. Genet.5, 1075–1080 (1996).
   PubMed Web of Science ®Google Scholar
• Stoll M, Corneliussen B, Costello CM et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat. Genet.36, 476−480 (2004).
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet361, 567–571 (2003).
   PubMed Web of Science ®Google Scholar
• Treloar SA, Wicks J, Nyholt DR. et al. Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26. Am. J. Hum. Genet.77, 365–376 (2005).
   PubMed Web of Science ®Google Scholar
• Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, Jacks T. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat. Med.11, 63–70 (2005).
   PubMed Web of Science ®Google Scholar
• Vignali M, Infantino M, Matrone R et al. Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Fertil. Steril.78, 665–678 (2002).
   PubMed Web of Science ®Google Scholar
• Cramer DW, Goldstein DP, Fraer C, Reichardt JK. Vagina agenesis (Mayer–Rokitansky–Kuster–Hauser syndrome) associated with the N314D mutation of galactose-1-phosphate urydil transferase (GALT). Mol. Hum. Reprod.2, 145–148 (1996).
   PubMed Web of Science ®Google Scholar
• Cramer DW, Hornstein MD, Ng WG, Barbieri RL. Endometriosis associated with the N314D mutation of galactose-1-phosphatase uridyl transferase (GALT). Mol. Hum. Reprod.85, 2897–2902 (1996).
   Google Scholar
• Stefansson H, Einarsdottir A, Geirssone RT et al Endometriosis is not associated with or linked to the GALT gene. Fertil. Steril.76, 1019–1022 (2001).
   PubMed Web of Science ®Google Scholar
• Hadfield RM, Manek S, Nakago S. et al. Absence of a relationship between endometriosis and the N314D polymorphism of galactose-1-phosphate uridyl tranferase in a UK population. Mol. Hum. Reprod.5, 990–993 (1999).
   PubMed Web of Science ®Google Scholar
• He C, Song Y, He X, Zhang W, Liao L. No association of endometriosis with galactose-1-phosphate uridyl transferase mutations in a Chinese population. Environ. Mol. Mutagen.47, 307–309 (2006).
   PubMed Web of Science ®Google Scholar
• Bulun SE, Zeitoun KM, Takayama K, Sasano H. Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance. J. Mol. Endocrinol.25, 35–42 (2000).
   PubMed Web of Science ®Google Scholar
• Bulun SE, Zeitoun KM, Kilic G. Expression of dioxin-related transactivating factors and target genes in human eutopic endometrial and endometriotic tissues. Am. J. Obstet. Gynecol.182, 767–775 (2000).
   PubMed Web of Science ®Google Scholar
• Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. Genetic polymorphisms of the CYP genes, alone or in combination, as a risk modifier to tobacco-related cancers. Cancer Epidemiol Biomarkers Prev.9, 3–28 (2000).
   PubMed Web of Science ®Google Scholar
• Watanabe T, Imoto I, Kosugi Y et al. Human arylhydrocarbon receptor repressor (AHRR) gene: genomic structure and analysis of polymprphisms in endometriosis. J. Hum. Genet.46, 342–346 (2001).
   PubMed Web of Science ®Google Scholar
• Asghar T, Yoshida S, Nakago S et al. Lack of association between endometriosis and the CYP17 MspA1 polymorphism in UK, Japanese populations. Gynecol. Endocrinol.20, 59–63 (2005).
   PubMed Web of Science ®Google Scholar
• Sarhanis P, Redman C, Perret C et al. Epithelial ovarian cancer: influence of polymorphism at the glutathione-S-transferase GSTM1 and GSTT1 loci on p53 expression. Br. J. Cancer74, 1757–1761 (1996).
   PubMed Web of Science ®Google Scholar
• Lear JT, Heagerty AH, Smith A et al. Multiple cutaneous basal cells carcinomas: glutathione-S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumor numbers and accrual. Carcinogenesis17, 1891–1896 (1996).
   PubMed Web of Science ®Google Scholar
• Hand PA, Inskip A, Gilford J. et al. Allelism at the glutathione –S-transferase GSTM3 locus: interactions with GSTM1 and GSTT1 as risk factors for astrocytoma. Carcinogenesis17, 1919–1922 (1996).
   PubMed Web of Science ®Google Scholar
• Baranova H, Bothorishvilli R, Canis M. et al. Glutation S-transferase M1 gene polymorphism and susceptibility to endometriosis in a French population. Mol. Hum. Reprod.3, 775–780 (1997).
   PubMed Web of Science ®Google Scholar
• Lin J, Zhang X, Quian Y et al. Glutatione S-transferase M1 and T1 genotypes and endometriosis risk : a case–control study. Chin. Med. J.116, 777–780 (2003).
   PubMed Web of Science ®Google Scholar
• Baxter SW, Thomas EJ, Campbell IG. GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer. Carcinogenesis.22, 63–65 (2001).
   PubMed Web of Science ®Google Scholar
• Guo SW. Glutathione S-transferases M1/T1 gene polymorphisms and endometriosis: a meta-analysis of genetic association studies. Mol. Hum. Reprod.11, 729–743 (2005).
   PubMed Web of Science ®Google Scholar
• Nakago S, Hadfield RM, Zondervan KT et al. Association between endometriosis and N-acetyl transferase 2 – polymorphism in a UK population. Mol. Hum. Reprod.7, 1079–1083 (2001).
   PubMed Web of Science ®Google Scholar
• Risch A, Wallace DM, Bathers S, Sim E. Slow N-acetylation genotype is a susceptibility factor in occupational and smoked related bladder cancer. Hum. Mol. Genet.4, 231–236 (1995).
   PubMed Web of Science ®Google Scholar
• Baranova H, Canis M, Ivaschenko T et al. Molecular events in the endometrium. Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis. Mol. Hum. Reprod.5, 636–641 (1999).
   PubMed Web of Science ®Google Scholar
• Deguchi M, Yoshida S, Kennedy S, Ohara N, Motoyama S, Maruo T. Lack of association between endometriosis and N-acetyl transferase 1 (NAT1) and 2 (NAT2) polymorphisms in a Japanese population. J. Soc. Gynecol. Investig.12, 208–213 (2005).
   PubMedGoogle Scholar
• Olive DL, Schwartz LJ. Endometriosis. N. Engl. J. Med.328, 1759–1769 (1993).
   PubMed Web of Science ®Google Scholar
• Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Tetranucleotide repeat polymorphism at the human aromatase cytochrome P450 gene (CYP19). Nucleic Acids Res.19, 195–20 (1991).
   PubMed Web of Science ®Google Scholar
• Kado N, Kitawaki J, Obayashi H et al. Association of the CYP 17 gene and CYP 19 gene polymorphisms with risk of endometriosis in Japanese women. Hum. Reprod.17, 897–902 (2002).
   PubMed Web of Science ®Google Scholar
• Georgiou I, Syrrou M, Bouba I et al. Association of estrogen receptor gene polymorphisms with endometriosis. Fertil. Steril.72, 164–166 (1999).
   PubMed Web of Science ®Google Scholar
• Kitawaki J, Obayashi H, Ishihara H et al. Oestrogenreceptor-α gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. Hum. Reprod.16, 51–55 (2001).
   PubMed Web of Science ®Google Scholar
• Luisi S, Galleri L, Marini F, Ambrosini G, Brandi ML, Petraglia F. Estrogen receptor gene polymorphisms are associated with recurrence of endometriosis. Fertil. Steril.85, 764–766 (2006).
   PubMed Web of Science ®Google Scholar
• Hsieh YY, Wang YK, Chang CC, Lin CS. Estrogen receptor α-351 XbaI*G and -397 PvuII*C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma. Mol. Hum. Reprod.13, 117–122 (2007).
   PubMed Web of Science ®Google Scholar
• Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O’Malley BW, McDonnell DP. Human progesterone receptor A form is a cell and promoter-specific repressor of human progesterone receptor B function. Mol. Endocrinol.7, 1244–1255 (1993).
   PubMed Web of Science ®Google Scholar
• McKenna NJ, Kieback DG, Carney DN, Fanning R, McLinden J, Headon DR. A germline taqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma. Br. J. Cancer71, 451–455 (1995).
   PubMed Web of Science ®Google Scholar
• Lancaster JM, Berchuck A, Carney ME, Wiseman R, Taylor JA. Progesterone receptor polymorphism and risk for breast and ovarian cancer. Cancer Res..78, 277–281 (1998).
   Google Scholar
• Tong D, Fabjani G, Heinze G, Obermair A, Leodolter S, Zellinger R. Analysis of human progesterone receptor gene polymorphism PROGINS in Austrian ovarian carcinoma patients. Clin. Endocrinol.95, 394–397 (2001).
   Google Scholar
• Tong D, Fabjani G, Heinze G, Zellinger R. No association between the human receptor gene polymorphism PROGINS and risk for ovarian carcinoma in Austrian women. Int. J. Cancer101, 203 (2002).
   Web of Science ®Google Scholar
• Whittemore AS, McGuire V. Analysis of human progesterone receptor gene polymorphism in Austrian ovarian cancer patients. Int. J. Cancer101, 202 (2002).
   PubMed Web of Science ®Google Scholar
• Wieser F, Schneeberger C, Tong D, Temfer C, Huber JC, Wenzl R. PROGINS receptor gene polymorphism is associated with endometriosis. Fertil. Steril.77, 309–312 (2002).
   PubMed Web of Science ®Google Scholar
• Lattuada D, Somigliana E, Viganò P, Candiani M, Pardi G, Di Blasio AM. Genetics of endometriosis: a role for the progesterone receptor gene polymorphism PROGINS? Clin. Endocrinol.61, 190–194 (2004).
   PubMed Web of Science ®Google Scholar
• Berchuck A, Schildkraut JM, Wenham RM et al. Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers. Cancer Epidemiol. Biomarkers Prev.13, 2141–2147 (2004).
   PubMed Web of Science ®Google Scholar
• van Kaam KJ, Romano A., Schouten PG, Dunselman GA, Groothuis PG. Progesterone receptor polymorphism +331G/A is associated with a decreased risk of deep infiltrating endometriosis. Hum. Reprod.22, 129–135, (2007).
   PubMed Web of Science ®Google Scholar
• Hickey T, Chandy A, Norman RJ. The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. J. Clin. Endocrinol. Metab.87, 161–165 (2002).
   PubMed Web of Science ®Google Scholar
• Westberg L, Baghaei F, Rosmond R et al. Polymorphisms of the androgen receptor gene and estrogen receptor β gene are associated with androgen levels in women. J. Clin. Endocrinol. Metab.86, 2562–2568 (2001).
   PubMed Web of Science ®Google Scholar
• Giguere Y, Dewailly E, Brisson J et al. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population. Cancer Res.61, 5869–5874 (2001).
   PubMed Web of Science ®Google Scholar
• Santarosa M, Bidoli E, Gallo A, Steffan A, Boiocchi M, Viel A. Polymorphic CAG repeat length within the androgen receptor gene. Identification of a subgroup of patients with increased risk of ovarian cancer. Oncol. Rep.9, 639–644 (2002).
   PubMed Web of Science ®Google Scholar
• Hsieh YY, Chang CC, Tsai FJ, Wu JY, Tsai CJ, Tsai HD. Androgen receptor trinucleotide polymorphism in endometriosis. Fertil. Steril.76, 412–413 (2001).
   PubMed Web of Science ®Google Scholar
• Lattuada D, Viganò P, Somigliana E, Odorizzi MP, Vignali M, Di Blasio AM. Androgen receptor gene cytosine, adenine, and guanine trinucleotide repeats in patients with endometriosis. J. Soc. Gynecol. Investig.11, 237–240 (2004).
   PubMedGoogle Scholar
• Mifsud A, Ramirez S, Young EL. Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries. J. Clin. Endocrinol. Metab.85, 3484–3488 (2000).
   PubMed Web of Science ®Google Scholar
• Edwards A, Hammond HA, Jin L et al. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics.12, 241–253 (1992).
   PubMed Web of Science ®Google Scholar
• Braun DP, Dmowski WP. Endometriosis: abnormal endometrium and dysfunctional immune response. Curr. Opin. Obstet. Gynecol.10, 365–369 (1998).
   PubMed Web of Science ®Google Scholar
• Kuper W, Schultze-Mosgau A, Diedich K. Paracrine changes in the peritoneal environment of women with endometriosis. Hum. Reprod. Update4, 719–723 (1998).
   PubMed Web of Science ®Google Scholar
• Sharpe-Timms KL. Basic research in endometriosis. Obstet. Gynecol. Clin. North Am.24, 269–290 (1997).
   PubMed Web of Science ®Google Scholar
• Ho HN, Wu MY, Yang YS. Peritoneal cell immunity and endometriosis. Am. J. Reprod. Immunol.38, 400–412 (1997).
   PubMed Web of Science ®Google Scholar
• Lebovic DI, Muller M, Taylor RN. Immunobiology of endometriosis. Fertil. Steril.75, 1–10 (2001).
   PubMed Web of Science ®Google Scholar
• Viganò P, Gaffuri B, Somigliana E, Busacca M, Di Blasio AM, Vignali M. Expression of intercellular adhesion molecole (ICAM)-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture. Mol. Hum. Reprod.4, 1150–1156 (1998).
   PubMed Web of Science ®Google Scholar
• Viganò P, Infantino M, Lattuada D et al. Intercellular adhesion molecole-1 (ICAM-1) gene polymorphisms in endometriosis. Mol. Hum. Reprod..9, 47–52 (2003).
   PubMed Web of Science ®Google Scholar
• Yamashita M, Yoshida S, Kennedy S, Ohara N, Motoyama S, Maruo T. Association study of endometriosis and intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms in a Japanese population. J. Soc. Gynecol. Investig.12, 267–271 (2005).
   PubMedGoogle Scholar
• Kitawaki J, Kiyomizu M, Obayashi H. et al. Synergistic effect of interleukin-6 promoter (IL6 -634C/G) and intercellular adhesion molecule-1 (ICAM-1 469K/E) gene polymorphisms on the risk of endometriosis in Japanese women. Am. J. Reprod. Immunol.56, 267–274 (2006).
   PubMed Web of Science ®Google Scholar
• Zondervan K, Cardon L, Kennedy S. Development of a web site for the genetic epidemiology of endometriosis. Fertil. Steril.78, 777–781 (2002).
   PubMed Web of Science ®Google Scholar
• Hsieh YY, Chang CC, Tsai FJ et al. Polymorphisms for interleukin 1-β (il-1 β)-511 promoter, Il-1 β exon 5 and Il-1 receptor antagonist: non association with endometriosis. J. Assist. Reprod. Genet..18, 506–511 (2001).
   PubMed Web of Science ®Google Scholar
• Hsieh YY, Chang CC, Tsai FJ, Hsu Y, Tsai HD, Tsai CH. Polymorphisms for interleukin 4 (IL-4) -590 promoter, Il-4 intron 3 and tumor necrosis factor α -308 promoter: non association with endometriosis. J. Clin. Lab. Anal.16, 121–126 (2002).
   PubMed Web of Science ®Google Scholar
• Bhanoori M, Babu KA, Deenadayal M, Kennedy SH, Shivaji S. The interleukin-6 -174G/C promoter polymorphism is not associated with endometriosis in South Indian women. J. Soc. Gynecol. Investig.12, 365–369 (2005).
   PubMedGoogle Scholar
• Wieser F, Fabjani G, Temfer C et al. Tumor necrosis factor α promoter polymorphisms and endometriosis. J. Soc. Gynecol. Investig.9, 313–318 (2002).
   PubMedGoogle Scholar
• Kitawaki J, Obayashi H, Otha M. et al. Genetic contribution of the interleukin 10 promoter polymorphism in endometriosis susceptibility. Am. J. Reprod. Immunol.47, 12–18 (2002).
   PubMed Web of Science ®Google Scholar
• Wieser F, Fabjani G, Tempfer C. et al. Analysis of the interleuhin-6 gene promoter polymorphism in women with endometriosis by pyrosequencing. J. Soc. Gynecol. Investig.10, 32–36 (2003).
   PubMedGoogle Scholar
• Jones KD, Sutton C. Endometriosis: an invasive disease. Gynecol. Endosc.10, 79–82 (2001).
   Google Scholar
• Jimbo H, Hitomi Y, Yoshikawa H. et al. Evidence for monoclonal expansion of epithelial cells in ovarian endometrial cysts. Am. J. Pathol.150, 1173–117 (1997).
   PubMed Web of Science ®Google Scholar
• Bergqvist A, Borg A, Ljungberg O. Protooncogenes in endometriotic and endometrial tissue Ann. NY Acad. Sci.626, 276–283 (1991).
   PubMedGoogle Scholar
• Thomas E, Campbell I. Evidence that endometriosis behaves in a malignant manner. Gynecol. Obstet. Invest.50, 2–10 (2000).
   PubMed Web of Science ®Google Scholar
• Jiang X, Hitchcock A, Bryan E et al. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res.56, 3534–3539 (1996).
   PubMed Web of Science ®Google Scholar
• Erzen M, Rakar S, Klancar B, Syrjanen K. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinoma as suggested by a nested case–control study. 83(1), 100–108 (2001).
   Google Scholar
• Jiang X, Morland S, Hitchcock A, Thomas E, Campbell I. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage. Cancer Res.58, 1707–1712 (1998).
   PubMed Web of Science ®Google Scholar
• Sato N, Tsunoda H, Nishida M et al. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res.60, 7052–7056 (2000).
   PubMed Web of Science ®Google Scholar
• Hsieh YY, Tsai FJ, Chang CC. et al. P21 gene codon 31 arginine/serine polymorphism: non association with endometriosis J. Clin. Lab. Anal.15, 184–187 (2001).
   PubMed Web of Science ®Google Scholar
• Chang CC, Hsieh YY, Tsai FJ, Tsai CH, Tsai HD, Lin CC. The praline form of the p53 codon 72 polymorphism is associated with endometriosis. Fertil. Steril.77, 43–45 (2002).
   PubMed Web of Science ®Google Scholar
• Hsieh YY, Lin CS. P53 codon 11, 72, and 248 gene polymorphisms in endometriosis. Int. J. Biol. Sci.2, 188–193 (2006).
   PubMed Web of Science ®Google Scholar
• Lattuada D, Viganò P, Spmigliana E, Abbiati A, Candiani M, Di Blasio AM. Analysis of the codon 72 polymorphism of the TP53 gene in patients with endometriosis. Mol. Hum. Reprod.10, 651–654 (2004).
   PubMed Web of Science ®Google Scholar
• Kim SH, Choi YM, Choung SH, Jun JK, Kim JG, Moon SY. Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis. Hum. Reprod.20, 2904–2908 (2005).
   PubMed Web of Science ®Google Scholar
• Bhanoori M, Arvind Babu K, Pavankumar Reddy NG et al. The vascular endothelial growth factor (VEGF) +405G>C 5´-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study. Hum. Reprod.20, 1844–1849 (2005).
   PubMed Web of Science ®Google Scholar
• Zondervan KT, Cardon LR, Kennedy SH. What makes a good case–control study? Design issues for complex traits such as endometriosis. Hum. Reprod.17, 1415–1423 (2002).
   PubMed Web of Science ®Google Scholar